Lincoln, Nebraska – February 5, 2019 – TELCOR Inc is honored to be a sponsor of the 2019 Molecular Medicine Tri-Con conference. This annual conference focuses on molecular medicine, specifically on discovery, genomics, diagnostic and information technology.
Going on its 26th year, more than 3,700 professionals will attend this annual conference to discuss and debate changes in the industry while at the same time, acquire tangible solutions to overcoming barriers to coverage.
As an industry leader in helping laboratories become efficient and improve collections for services provided, TELCOR is excited to announce Kurt Matthes, RCM vice president, will speak Sunday, March 10 at 2:00 p.m. on coverage and reimbursement for advanced diagnostics.
“There are many challenges facing laboratories today,” said Matthes. “This discussion will focus on the difficulties in securing reimbursement as healthcare in the U.S. transforms itself from an activity-based fee-for-service system to tying provider reimbursement to improved patient outcomes, savings and quality metrics.”
To discover how TELCOR RCM provides tools to overcome tough challenges and improve profitability, please contact the Marketing Director at 402-489-1207 or email@example.com.
TELCOR is the proven leader of revenue cycle management software and service solutions. Laboratories are empowered to improve billing processes by streamlining the revenue cycle workflow, thus reducing labor-intensive processes and operating costs. The TELCOR software application, TELCOR RCM, and the billing service, TELCOR Revenue Cycle Services, provide a high level of visibility to business operations, allowing managers the ability to make more informed decisions. Reducing labor costs, increasing efficiencies and improving key performance indicators help laboratories increase collections and improve profitability.